RxSight, Inc.
Company Stats
- Market Cap
- $203.8M
- as of Sep 30, 2026
- Shares Outstanding
- 41.6M
- Free Float
- 76.5%
Income Statement
- Revenue
- $134.5M
- Operating Income
- -$48.2M
- Net Income
- -$38.9M
- EBITDA
- -$44.9M
- Revenue Growth, 3Y
- 40.0%
- FCF Margin, 3Y Avg
- -27.5%
- FCF Margin, Worst Year
- -52.1%
Cash Flow
- Free Cash Flow
- -$19.3M
- FCF Yield
- -9.5%
- Owner FCF Yield
- -25.0%
Balance Sheet
- Cash & Equivalents
- $19.9M
Returns & Capital
- SBC, 3Y Avg
- $24.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $134.5M | -$19.3M | -14.4% |
| FY2024 | $139.9M | -$22.4M | -16.0% |
| FY2023 | $89.1M | -$46.4M | -52.1% |
| FY2022 | $49.0M | -$61.2M | -125.0% |
| FY2021 | $22.6M | -$46.6M | -206.5% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 10, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Earnings
Other Coverage
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 6, 2026
Small-Cap Signal
Small Caps Leverage Pricing Power Amidst Input Volatility
July 9, 2026
Small-Cap Signal
Agentic AI Drives Explosive Small-Cap Infrastructure Demand
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 6, 2026
Small-Cap Signal
Small Caps Leverage Pricing Power Amidst Input Volatility
July 9, 2026
Small-Cap Signal
Agentic AI Drives Explosive Small-Cap Infrastructure Demand